Contrast-induced acute kidney injury
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Hospitalized patients (2) Age 18 or above (3) Informed consent and strict adherence to the research protocol (4) The range of eGFR that meets the definition of CKD3 stage is 30-60mL/min/1.73m2 (excluding 60mL/min/1.73m2), and eGFR is calculated using the CKD-EPI formula
Exclusion criteria
Exclusion criteria: (1) Allergic to iodine contrast agents; (2) pregnant or lactating persons; (3) Patients with hyperthyroid or asthma; (4) pancreatitis, intestinal obstruction, gastrointestinal dysfunction, etc. before and after the examination can not drink water; (5) Patients who cannot stop metformin 2 days before and after the examination due to the need of disease; (6) accompanied by serious systemic diseases, such as severe heart failure (LVEF < 35% or NYHA grade IV), acute heart failure, kidney failure, etc.; (7) Patients who have taken any nephrotoxic drugs such as aminoglycoside, vancomycin, cephalosporin or aspirin within 48 hours or several hours before the examination; (8) Serum creatinine value (sCr) was measured in the week before intravenous administration of iodine contrast agent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of CI-AKI 48 to 72 hours after administration of contrast agent; | — |
Secondary
| Measure | Time frame |
|---|---|
| The mean relative increase in serum creatinine levels from baseline 2 to 3 days after administration of the contrast agent;adverse event; | — |
Countries
China
Contacts
the First Affiliated Hospital of Jinan University